BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Wang HQ, Wang AC, Li YX, Ding SS, An XJ, Shi HY. Overexpression of Forkhead box Q1 correlates with poor prognosis in papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2019;90:334-42. [PMID: 30378716 DOI: 10.1111/cen.13896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Xi H, He Z, Lv C. FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma. Mol Med Rep 2021;24:651. [PMID: 34278485 DOI: 10.3892/mmr.2021.12290] [Reference Citation Analysis]
2 Han X, Guo X, Zhang W, Cong Q. MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1. Onco Targets Ther 2019;12:4813-24. [PMID: 31417280 DOI: 10.2147/OTT.S207593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Li P, Pan X, Zheng Z, Sun Y, Han Y, Dong J, Lu M. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1. Horm Metab Res 2021;53:625-32. [PMID: 34496413 DOI: 10.1055/a-1560-2827] [Reference Citation Analysis]
4 Wang T, Tian K, Ji X, Song F. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma. Medicine (Baltimore) 2021;100:e27308. [PMID: 34622829 DOI: 10.1097/MD.0000000000027308] [Reference Citation Analysis]